UBS raised the firm’s price target on Charles River (CRL) to $175 from $170 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River Labs divests units to sharpen profitability focus
- Iqvia to acquire certain discovery services assets from Charles River
- Charles River price target lowered to $235 from $251 at TD Cowen
- Charles River price target lowered to $175 from $215 at Mizuho
- Buy Rating on Charles River Labs: Attractive Entry Point as AI Fears Overhang Fundamentals and Multiple Expansion Potential